Statins for the primary prevention of cardiovascular disease
26 results
1 - 26
Statins for the primary prevention of cardiovascular disease- Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease
- HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
- Ezetimibe for the prevention of cardiovascular disease and all‐cause mortality events
- Fibrates for primary prevention of cardiovascular disease events
- HMG CoA reductase inhibitors (statins) for kidney transplant recipients
- PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
- Niacin for primary and secondary prevention of cardiovascular events: Cochrane systematic review
- Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia
- Statins for primary prevention of venous thromboembolism: Cochrane systematic review
- Preoperative statin therapy for adults undergoing cardiac surgery
- Statins for the primary prevention of venous thromboembolism
- Fibrates for secondary prevention of cardiovascular disease and stroke
- Interventions to improve adherence to lipid‐lowering medication
- Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease
- Dietary advice for reducing cardiovascular risk
- Mobile phone‐based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults
- Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery